WallStreetZenWallStreetZen

NASDAQ: VTRS
Viatris Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VTRS

Based on 8 analysts offering 12 month price targets for Viatris Inc.
Min Forecast
$10.00-17.01%
Avg Forecast
$13.25+9.96%
Max Forecast
$16.00+32.78%

Should I buy or sell VTRS stock?

Based on 9 analysts offering ratings for Viatris Inc.
Buy
Strong Buy
2 analysts 22.22%
Buy
1 analysts 11.11%
Hold
6 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VTRS stock forecasts and price targets.

VTRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 17%
17
Strong BuyMaintains$15.00+23.15%2023-02-01
Jefferies
Top 28%
73
Strong BuyUpgrades$15.00+23.15%2023-01-27
JP Morgan
Bottom 42%
42
HoldMaintains$14.00+14.94%2022-11-15
UBS
Bottom 11%
11
HoldUpgrades$12.00-1.48%2022-11-10
Piper Sandler
Top 15%
86
HoldUpgrades$10.00-17.90%2022-11-08
BMO Capital
Top 14%
87
BuyMaintains$16.00+31.36%2022-08-09
Anonymous
Goldman Sachs
HoldMaintains$11.00-9.69%2022-05-12
Citigroup
Bottom 21%
21
HoldMaintains$11.00-9.69%2022-03-10
Bank of America
Top 20%
81
HoldDowngrades$13.00+6.73%2022-03-01
Raymond James
Bottom 8%
8
HoldDowngradesN/AN/A2022-03-01

1 of 1

Forecast return on equity

Is VTRS forecast to generate an efficient return?
Company
N/A
Industry
0.07%
Market
13.24%

Forecast return on assets

Is VTRS forecast to generate an efficient return on assets?
Company
N/A
Industry
0.05%

VTRS earnings per share forecast

What is VTRS's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$3.28+396.97%
Avg 2 year Forecast
$3.28+396.97%
Avg 3 year Forecast
$3.32+403.03%
VTRS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

VTRS revenue forecast

What is VTRS's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$15.9B-5.02%
Avg 2 year Forecast
$15.8B-5.34%
Avg 3 year Forecast
$15.7B-6.43%
VTRS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VTRS earnings growth forecast

How is VTRS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
71.19%
Industry
21.67%
Market
21.99%
VTRS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
VTRS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
VTRS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

VTRS revenue growth forecast

How is VTRS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
-2.13%
Industry
8.78%
Market
9.21%
VTRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VTRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VTRS vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
VTRS$12.18$13.25+8.78%Buy
TEVA$10.76$10.63-1.25%Hold
CTLT$56.05$81.71+45.79%Buy
RDY$53.09$67.00+26.20%Strong Buy
ELAN$13.87$18.00+29.78%Hold
View Top Pharmaceutical Stocks

Viatris Stock Forecast FAQ

Is Viatris Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: VTRS) stock is to Buy VTRS stock.

Out of 9 analysts, 2 (22.22%) are recommending VTRS as a Strong Buy, 1 (11.11%) are recommending VTRS as a Buy, 6 (66.67%) are recommending VTRS as a Hold, 0 (0%) are recommending VTRS as a Sell, and 0 (0%) are recommending VTRS as a Strong Sell.

If you're new to stock investing, here's how to buy Viatris stock.

What is VTRS's earnings growth forecast for 2023-2025?

(NASDAQ: VTRS) Viatris's forecast annual earnings growth rate of 71.19% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 21.67%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 21.99%.

Viatris's earnings in 2023 is $803,600,000.On average, 6 Wall Street analysts forecast VTRS's earnings for 2023 to be $3,977,605,481, with the lowest VTRS earnings forecast at $3,868,463,868, and the highest VTRS earnings forecast at $4,171,635,017. On average, 4 Wall Street analysts forecast VTRS's earnings for 2024 to be $3,977,605,481, with the lowest VTRS earnings forecast at $3,807,829,638, and the highest VTRS earnings forecast at $4,317,157,169.

In 2025, VTRS is forecast to generate $4,026,112,865 in earnings, with the lowest earnings forecast at $3,819,956,484 and the highest earnings forecast at $4,450,552,475.

What is VTRS's revenue growth forecast for 2023-2025?

(NASDAQ: VTRS) Viatris's forecast annual revenue growth rate of -2.13% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.21%.

Viatris's revenue in 2023 is $16,728,300,000.On average, 4 Wall Street analysts forecast VTRS's revenue for 2023 to be $19,267,805,932,976, with the lowest VTRS revenue forecast at $18,885,864,855,413, and the highest VTRS revenue forecast at $19,802,072,322,894. On average, 4 Wall Street analysts forecast VTRS's revenue for 2024 to be $19,203,357,810,015, with the lowest VTRS revenue forecast at $18,329,000,088,011, and the highest VTRS revenue forecast at $19,790,212,267,525.

In 2025, VTRS is forecast to generate $18,982,515,817,873 in revenue, with the lowest revenue forecast at $17,910,502,633,241 and the highest revenue forecast at $19,693,512,797,681.

What is VTRS's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: VTRS) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.05%.

What is VTRS's Price Target?

According to 8 Wall Street analysts that have issued a 1 year VTRS price target, the average VTRS price target is $13.25, with the highest VTRS stock price forecast at $16.00 and the lowest VTRS stock price forecast at $10.00.

On average, Wall Street analysts predict that Viatris's share price could reach $13.25 by Feb 1, 2024. The average Viatris stock price prediction forecasts a potential upside of 8.78% from the current VTRS share price of $12.18.

What is VTRS's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: VTRS) Viatris's current Earnings Per Share (EPS) is $0.66. On average, analysts forecast that VTRS's EPS will be $3.28 for 2023, with the lowest EPS forecast at $3.19, and the highest EPS forecast at $3.44. On average, analysts forecast that VTRS's EPS will be $3.28 for 2024, with the lowest EPS forecast at $3.14, and the highest EPS forecast at $3.56. In 2025, VTRS's EPS is forecast to hit $3.32 (min: $3.15, max: $3.67).

What is VTRS's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: VTRS) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.